In summary, we screened out TGFBI gene in platelet-treated ovarian cancer cells through combination of our private microarray results with GEO data, and verified its prognostic value in ovarian cancer using cohorts from TCGA and tissue microarray. This evidence concerns the gene TGFBI and ovarian carcinoma.